Average Co-Inventor Count = 6.42
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (69 from 2,405 patents)
2. Schering Corporation (10 from 1,829 patents)
3. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)
4. Pharmacopeia Inc. (4 from 101 patents)
5. Walter and Eliza Hall Institute of Medical Research (1 from 83 patents)
79 patents:
1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
2. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
3. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
4. 12240867 - Arginase inhibitors and methods of use
5. 12215116 - Arginase inhibitors and methods of use
6. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
7. 11766435 - N3-substituted iminopyrimidinones as antimalarial agents
8. 11702430 - Aza-benzothiophene compounds as STING agonists
9. 11685761 - Cyclic di-nucleotide compounds as sting agonists
10. 11466047 - Cyclic di-nucleotide compounds as sting agonists
11. 11453697 - Cyclic di-nucleotide compounds as sting agonists
12. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
13. 11312772 - Combinations of PD-1 antagonists and benzo [b] thiophene STING agonists for cancer treatment
14. 11285131 - Benzo[b]thiophene STING agonists for cancer treatment
15. 11274111 - Arginase inhibitors and methods of use